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The data here consists of calcium imaging of human neuro-
blastoma SH-SY5Y cells treated with the calcium-sensitive dye
Fluo-4AM and then incubated with nanomolar concentrations of
either human or rat Alzheimer’s β-amyloid peptide Aβ1-42. These
data are both of a qualitative (ﬂuorescence micrographs) and semi-
quantitative nature (estimation of intracellular calcium con-
centrations of cells probed by Aβ1-42 peptides vs. control
untreated cells). Since rat Aβ1-42 differs from its human coun-
terpart at only three amino acid positions, this comparative study
is a good assessment of the speciﬁcity of the amyloid pore forming
assay. The interpretation of this dataset is presented in the
accompanying study “Broad neutralization of calcium-permeable
amyloid pore channels with a chimeric Alzheimer/Parkinson pep-
tide targeting brain gangliosides” [1].
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
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Fantini).
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ject areaMolecular basis of neurodegenerative diseasesype of data Text ﬁle and ﬁgures
ow data was
acquiredFluorescent microscopeata format Analyzed
xperimental
factorsCells treated with the calcium-sensitive dye Fluo-4AM and then incubated with
either human or rat Aβ1-42 peptide.xperimental
featuresControl cells are preloaded with Fluo-4AM and then treated with buffer alone to
determine background intracellular calcium levels. This background is sub-
tracted from the values induced by either human or rat Aβ1-42.
ata source
locationNot applicableata accessibility All data are presented in this articleD
Value of the data
 The data provides a comparative study of Ca2þ ﬂuxes induced by human and rat forms of Aβ1-42
peptide.
 The comparison of the Ca2þ ﬂuxes induced by human and rat Aβ1-42 peptides may be used as an
internal reference to validate this assay for studying amyloid pore formation induced by any
amyloid protein in living neural cells.
 Researchers interested in testing amyloid pore formation and inhibitors of amyloid pores might
carefully choose positive and negative controls with calibrated compounds.1. Data
Amyloid pores [1–4] are responsible for a dramatic increase of intracellular Ca2þ levels in brain
cells that can be measured by ﬂuorescence microscopic imaging [5–12]. The dataset presented here
contains the values of intracellular Ca2þ concentrations induced by human and rat Aβ1-42 peptides
in neural SH-SY5Y cells. Amino acid sequence alignments of these peptides are presented in Fig. 1.
Quantitative data (histograms) are given in Fig. 1, and ﬂuorescence micrographs are shown in Fig. 2.2. Experimental design, materials and methods
2.1. Materials
SH-SY5Y cells were obtained from ATCC. Dulbecco's Modiﬁed Eagle Medium: Nutrient Mixture F12
(DMEM/F12), HBSS, glutamine and penicillin/streptomycin were furnished by Gibco. Fluo-4AM was
from Invitrogen. Human and rat Aβ1-42 peptides were purchased from rPeptide. The purity of these
peptides was 495% as assessed by HPLC.
2.2. Cell culture
SH-SY5Y cells were cultured in DMEM/F12 supplemented with 10% fetal calf serum, glutamine
(2 mM) and penicillin (50 U/mL)/streptomycin (50 mg/mL) and maintained at 37 °C with 5% CO2. Cells
were passaged twice a week and not used beyond passage 25.
Fig. 2. Cell imaging of Ca2þ ﬂuxes induced by human and rat Aβ1-42 peptides in SH-SY5Y cells: a comparative study. The
images show pseudocolor representations of cells (scale bar: 100 mm), warmer colors corresponding to higher ﬂuorescence. The
photographs are taken after 60 min of incubation with each peptide (same experimental conditions as in Fig. 1).
Fig. 1. Ca2þ ﬂuxes induced by human and rat Aβ1-42 peptides in SH-SY5Y cells: a comparative study. Amino acid sequence
alignments (upper panel) show that human and rat Aβ1-42 peptides differ at only three positions, all located in the gang-
lioside-binding domain (GBD) [1,12]. SH-SY5Y cells treated with the calcium dye Fluo-4AM were incubated with human Aβ1-
42 (blue histogram, n¼87) or rat Aβ1-42 (red histogram, n¼120) and calcium-dependent ﬂuorescence was recorded after
60 min of incubation with the indicated peptides (lower panel). Results are expressed as mean7SEM. Statistical signiﬁcance
between human and rat Aβ1-42 (p¼2.751011) was evaluated by using Student's t-test.
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SH-SY5Y cells were plated (45.000 cells/dish) in 35 mm culture dishes and grown during 72 h at
37 °C. They were loaded with 5 mM Fluo-4AM for 30 min in the dark as previously described [1,5]. The
calcium ﬂuxes were estimated by measuring the variation of cell ﬂuorescence intensity after the
injection of either rat or human Aβ1-42 (220 nM) into the recording chamber directly above an
upright microscope objective (BX51W Olympus) equipped with an illuminator system MT20 module.
Fluorescence emission at 525 nm was imaged by a digital camera CDD (Hamanatsu ORCA-ER) after
ﬂuorescence excitation at 490 nm. Time-lapse images (1 frame/10 s) were collected using the CellR
Software (Olympus). Fluorescence intensity were measured from region of interest (ROI) centered on
individual cells. Signals were expressed as ﬂuorescence after treatment (Ft60) divided by the ﬂuor-
escence before treatment (F0) and multiplied by 100. The results were averaged and the ﬂuorescence
of control is subtracted of each value. The experiments were performed at 30 °C during 60 min. In the
C. Di Scala et al. / Data in Brief 6 (2016) 640–643 643pseudocolor representations of cells, warmer colors correspond to higher ﬂuorescence and thus to
higher Ca2þ levels.3. Statistical analysis
Quantitative data are expressed as mean7S.E.M. and the statistical signiﬁcance was assessed with
the Student's t-test.Acknowledgments
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